This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. Ontario is reporting three new cases of the novel coronavirus today, bringing the total in the province to 18. THE CANADIAN PRESS/AP-NIAID-RML via AP

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. Ontario is reporting three new cases of the novel coronavirus today, bringing the total in the province to 18. THE CANADIAN PRESS/AP-NIAID-RML via AP

Big unknowns about virus complicate getting back to normal

Big unknowns about virus complicate getting back to normal

WASHINGTON — Reopening the U.S. economy is complicated by some troubling scientific questions about the new coronavirus that go beyond the logistics of whether enough tests are available.

In an ideal world, we’d get vaccinated and then get back to normal. But, despite unprecedented efforts, no vaccine will be ready any time soon.

“We’re all going to be wearing masks for a while,” Dr. Rochelle Walensky, infectious diseases chief at Massachusetts General Hospital, predicted during a podcast with the Journal of the American Medical Association.

Three big unknowns top the worry list:

WHO’S CONTAGIOUS?

“The really unknown in this, to be completely transparent,” is asymptomatic spread, said Dr. Deborah Birx, the White House coronavirus task force co-ordinator.

From the beginning, authorities have rightly told people to stay home if they’re sick. But according to Dr. Anthony Fauci of the National Institutes of Health, somewhere between 25% and half of infected people might not show symptoms.

That means there’s no way to tell if you’re standing next to someone who’s contagious in the checkout line.

And even in people who eventually develop symptoms, it’s not clear exactly how soon after infection they can spread the virus. That’s one reason U.S. officials recently encouraged people to wear cloth masks in public, even as they try to keep 6 feet away from others.

To reopen the economy, officials are emphasizing the availability of more virus tests. That’s key to spotting and isolating the infected, and tracing and quarantining the people they may have exposed. But it’s not a panacea.

“If you get a test today, that does not mean that tomorrow or the next day or the next day or the next day as you get exposed, perhaps from someone who may not even know they’re infected, that that means ‘I’m negative,’” Fauci said at a recent White House briefing.

WHO’S IMMUNE?

Doctors assume people who had COVID-19 will have some immunity against a repeat infection. But they don’t know how much protection or how long it will last.

Another key question: Do people who survive a severe infection have stronger immunity than those who had mild symptoms — or those who had no obvious symptoms at all?

To tell, scientists are rolling out blood tests that look for antibodies, proteins that the immune system makes to fight off infection. They don’t detect active infection like the tests needed for the currently sick. They’re intended to tell who already was infected whether they knew it or not — including those who had few or no symptoms and those who were sick but couldn’t get a diagnostic test.

As they test more people, researchers will look for the level of antibodies that seems to be the key threshold for protection. They’re also trying to tell if having certain types of antibodies are more critical than an overall count.

“How long is the protection — one month, three months, six months, a year?” Fauci said. “We need to be humble and modest that we don’t know everything.”

Another hurdle: Dozens of antibody tests are being sold without proof that they work as promised. Some countries have reported wildly inaccurate results from certain tests. Among other things, scientists must prove the tests don’t confuse antibodies against another respiratory bug for COVID-19 protection.

The situation is so worrisome that FDA Commissioner Stephen Hahn recently warned that his agency has given “emergency use authorization” backing to just four tests — and that urgent work to validate others is underway.

WHO’S AT-RISK?

One early warning has borne out: Older adults are especially susceptible to COVID-19. So are people of any age who have certain health troubles, such as lung disease, heart problems or diabetes.

But being young and apparently healthy is no guarantee. Plenty of 20- and 30-somethings, and even some children, get infected and occasionally die.

“Some people do extremely well and some people completely crash,” Fauci told The Associated Press in a recent interview. “It’s something more than just age and underlying condition.”

There are theories. Maybe genetic differences play a role in how the body responds to this infection, particularly the overactive immune response — what’s called a “cytokine storm” — that is blamed for many deaths. Some scientists are looking into variations in cell receptors, the docking ports that allow the virus to stick to a cell and burrow inside.

Whatever the culprit, there’s no way to predict who’s going to crash. Yet that will become increasingly important if some of the experimental therapies being studied pan out, Fauci said, because doctors would need to know whether to focus treatment on the seriously ill or try to reach the newly infected quickly.

“If this acts like any other virus, you always want to hit it early,” he noted.

____

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content

Lauran Neergaard, The Associated Press

Coronavirus

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Alberta’s chief medical officer of health, Dr. Deena Hinshaw, said the 500 deaths from COVID-19 in the province are a tragic milestone. (Photo by Chris Schwarz/Government of Alberta)
Alberta hits ‘tragic milestone’ with more COVID-19 deaths

Province up to 500 COVID-19 deaths, adds 1,265 cases

Photo Submitted
Sylvan Lake Grade 2 students in Holiday Healing Campaign

Students in Nicole Eleniak’s class worked to share love and joy with other children this holiday

File photo by Red Deer Advocate
Programs, events and team activities cancelled at Sylvan Lake NexSource Centre

The new changes at the NexSource Centre are temporary and are a response the Provincial mandates

Alberta premier Jason Kenney declared a public health state of emergency Tuesday and sweeping new measures as COVID-19 cases in the province continue to rise. (photo by Chris Schwarz/Government of Alberta)
Kenney declares state of public health emergency as COVID-19 cases rise

High schools shift to online learning, businesses face new restrictions

The tree decorated in red decorations is called the Buffalo Plaid Cottage Tree. Papple says this tree has more of a "taditional, cottage-y feel." (Photo Submitted)
Sylvan Lake resident auctioning decorated Christmas trees to help local charities

Shauntel Papple is auctioning two fully decorated trees to benefit AACS and Youth Unlimited

Kyle Charles poses for a photo in Edmonton on Friday, Nov. 20, 2020. Marvel Entertainment, the biggest comic book publisher in the world, hired the 34-year-old First Nations illustrator as one of the artists involved in Marvel Voice: Indigenous Voices #1 in August. THE CANADIAN PRESS/Jason Franson
VIDEO: Indigenous illustrator of new Marvel comic hopes Aboriginal women feel inspired

Kyle Charles says Indigenous women around the world have reached out

(File photo)
Alberta woman charged after allegedly hitting boy with watermelon at B.C. campsite

Police say a disagreement among friends at an Adams Lake campsite turned ugly

A pedestrian wears masks while out walking in front of the Alberta Legislature as the COVID-19 numbers spike in Edmonton on Tuesday November 24, 2020. THE CANADIAN PRESS/Jason Franson
Doctor says Alberta restrictions not enough to reduceCOVID-19 strain on hospitals

Mithani notes people are still allowed to gather indoors at large places of worship and in bars,

Prime Minister Justin Trudeau speak to the media about the COVID-19 virus outside Rideau Cottage in Ottawa, Friday, Nov. 20, 2020. THE CANADIAN PRESS/Adrian Wyld
Canada’s inability to manufacture vaccines in-house will delay distribution: Trudeau

First doses of COVID-19 vaccine expected in first few months of 2021, prime minister says

This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
VIDEO: How do the leading COVID vaccines differ? And what does that mean for Canada?

All three of the drug companies are incorporating novel techniques in developing their vaccines

Ilaria Rubino is shown in this undated handout image at University of Alberta. Alberta researcher Rubino has developed technology allowing mostly salt to kill pathogens in COVID-19 droplets as they land on a mask. THE CANADIAN PRESS/HO-University of Alberta
Alberta researcher gets award for COVID-19 mask innovation

The salt-coated mask is expected to be available commercially next year after regulatory approval.

Russ and Luanne Carl are sharing about their experiences of fighting COVID-19 this past summer. (Photo submitted)
Stettler couple opens up about COVID-19 battle

Luanne and Russ Carl urge others to bolster personal safety measures amidst ongoing pandemic

This 2019 photo provided by The ALS Association shows Pat Quinn. Quinn, a co-founder of the viral ice bucket challenge, died Sunday, Nov. 22, 2020, at the age of 37. (Scott Kauffman/The ALS Association via AP)
Co-founder of viral ALS Ice Bucket Challenge dies at 37

Pat Quinn was diagnosed with Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis, in 2013

Most Read